Table 3.
Pooled data for immune responses in CIK cell treatment group and conventional chemotherapy.
| Study | Patient | CD3+ | CD4+ | CD8+ | CD4+/CD8+ | |
|---|---|---|---|---|---|---|
| Jiang, 2006 | 32 | Pre-therapy | 49.6±11.7 | 31.5±8.4 | 32.7±9.5 | 0.9±0.1 |
| Post-therapy | 58.2±11.7 | 38.5±9.7 | 28.6±5.1 | 1.4±0.2 | ||
| Liu, 2013 | 51 | Pre-therapy | 57.21±9.44 | 29.54±7.82 | 26.32±6.48 | 1.06±0.25 |
| Post-therapy | 66.75±9.81 | 38.12±8.02 | 19.62±5.92 | 1.37±0.29 | ||
| Shi, 2012 | 74 | Pre-therapy | 50.8±8.5 | 26.5±6.1 | NA | 0.9±0.4 |
| Post-therapy | 62.6±11.3 | 36.0±6.6 | NA | 1.4±0.3 | ||
| Zhao, 2013 | 25 | Pre-therapy | 48.95±6.89 | NA | NA | NA |
| Post-therapy | 80.7±9.21 | NA | NA | NA |